Used as an intermediate in the synthesis of angiotensin II receptor antagonists, particularly in the production of antihypertensive drugs like olmesartan medoxomil. Its structure allows for key molecular coupling in the development of medications that treat high blood pressure by blocking receptors involved in vasoconstriction. Commonly employed in pharmaceutical research and development for creating potent, long-acting antihypertensive agents with high receptor selectivity.